POST SORAFENIB SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: THE ROLE OF TUMOR PROGRESSION AND LIVER IMPAIRMENT

被引：0
|
作者：
Iavarone, M. [1 ]
Cabibbo, G. [2 ]
Biolato, M. [3 ]
Della Corte, C. [1 ]
Maida, M. [2 ]
Basso, M. [3 ]
Vavassori, S. [1 ]
Camma, C. [2 ]
Grieco, A. [3 ]
Craxi, A. [2 ]
Colombo, M. [1 ]
机构：
[1] Univ Milan, AM &A Migliavacca Ctr Liver Dis, Fdn IRCCS Ca Granda Maggiore Hosp, Div Gastroenterol 1, Milan, Italy
[2] Univ Palermo, Gastroenterol Sect, DIBIMIS, Policlin P Giaccone, Palermo, Italy
[3] UCSC Catholic Univ Rome, Dept Internal Med, Gemelli Hosp, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2014年 / 46卷
关键词：
D O I：
10.1016/j.dld.2014.01.082
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T-42
引用
收藏
页码：E35 / E36
页数：2
相关论文
共 50 条
  • [41] Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment
    Antonelli, Giulio
    Gigante, Elia
    Iavarone, Massimo
    Begini, Paola
    Sangiovanni, Angelo
    Iannicelli, Elsa
    Biondetti, Piero
    Pellicelli, Adriano M.
    Miglioresi, Lucia
    Marchetti, Paolo
    Lampertico, Pietro
    Marignani, Massimo
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2018, 6 (07) : 1039 - 1048
  • [42] The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrence
    Sinakos, Emmanouil
    Selvaggi, Gennaro
    Papalavrentios, Lavrentis
    Tzakis, Andreas
    Akriviadis, Evangelos
    ANNALS OF GASTROENTEROLOGY, 2011, 24 (03): : 228 - 230
  • [43] Sorafenib in advanced hepatocellular carcinoma
    Sauerbruch, T.
    Gonzalez-Carmona, A. M.
    Nitschmann, S.
    INTERNIST, 2009, 50 (11): : 1290 - 1292
  • [44] Sorafenib in advanced hepatocellular carcinoma
    Llovet, Josep M.
    Ricci, Sergio
    Mazzaferro, Vincenzo
    Hilgard, Philip
    Gane, Edward
    Blanc, Jean-Frederic
    Cosme de Oliveira, Andre
    Santoro, Armando
    Raoul, Jean-Luc
    Forner, Alejandro
    Schwartz, Myron
    Porta, Camillo
    Zeuzem, Stefan
    Bolondi, Luigi
    Greten, Tim F.
    Galle, Peter R.
    Seitz, Jean-Francois
    Borbath, Ivan
    Haussinger, Dieter
    Giannaris, Tom
    Shan, Minghua
    Moscovici, Marius
    Voliotis, Dimitris
    Bruix, Jordi
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04): : 378 - 390
  • [45] Sorafenib for Advanced Hepatocellular Carcinoma
    Shingina, Alexandra
    Hashim, ALMoutaz
    Haque, Mazhar
    Suen, Michael W.
    Yoshida, Eric M.
    Gill, Sharlene
    Weiss, Alan
    GASTROENTEROLOGY, 2012, 142 (05) : S42 - S42
  • [46] Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular Carcinoma
    Nakano, Masahito
    Tanaka, Masatoshi
    Kuromatsu, Ryoko
    Nagamatsu, Hiroaki
    Sakata, Kenji
    Matsugaki, Satoru
    Kajiwara, Masahiko
    Fukuizumi, Kunitaka
    Tajiri, Nobuyoshi
    Matsukuma, Norito
    Sakai, Terufumi
    Ono, Noriyuki
    Yano, Yoichi
    Koga, Hironori
    Kurogi, Junichi
    Takata, Akio
    Sumie, Shuji
    Satani, Manabu
    Yamada, Shingo
    Niizeki, Takashi
    Aino, Hajime
    Iwamoto, Hideki
    Torimura, Takuji
    Sata, Michio
    ONCOLOGY, 2013, 84 (02) : 108 - 114
  • [47] Role of Monocytes From Patients With Hepatocellular Carcinoma in Tumor Progression
    Asai, Akira
    Tsuchimoto, Yusuke
    Fukunishi, Shinya
    Tsuda, Yasuhiro
    Fukuda, Akira
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2012, 142 (05) : S923 - S923
  • [48] Determinants of Survival and Post-Progression Outcomes by Sorafenib-Regorafenib Sequencing for Unresectable Hepatocellular Carcinoma
    Lee, I-Cheng
    Chao, Yee
    Lee, Pei-Chang
    Chen, San-Chi
    Chi, Chen-Ta
    Wu, Chi-Jung
    Wu, Kuo-Cheng
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    CANCERS, 2022, 14 (08)
  • [49] Association of hypophosphatemia-occurring sorafenib with prognosis and hepatic impairment in patients with advanced hepatocellular carcinoma
    Aizawa, M.
    Mitsunaga, S.
    Okuyama, H.
    Nakachi, K.
    Ohno, I.
    Shimizu, S.
    Takahashi, H.
    Okusaka, T.
    Ochiai, A.
    Ikeda, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [50] Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
    Masayoshi Yada
    Akihide Masumoto
    Kenta Motomura
    Hirotaka Tajiri
    Yusuke Morita
    Hideo Suzuki
    Takeshi Senju
    Toshimasa Koyanagi
    World Journal of Gastroenterology, 2014, (35) : 12581 - 12587
12345